A month has gone by since the last earnings report for Roper Technologies (ROP) . Shares have lost about 4.5% in that time frame, underperforming the S&P 500.But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Roper Technologies due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important catalysts.Roper Q ...

In its upcoming report, Webtoon Entertainment (WBTN) is predicted by Wall Street analysts to post quarterly loss of -$0.04 per share, reflecting a decline of 33.3% compared to the same period last year. Revenues are forecasted to be $334.44 million, representing a year-over-year decrease of 5.2%.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projectio ...

Core Insights - United Therapeutics Corporation reported fourth-quarter results that exceeded earnings expectations but fell short on revenue, leading to a more than 9% increase in shares intra-day [1] Financial Performance - Adjusted earnings per share for the fourth quarter were $7.70, surpassing the consensus estimate of $7.10 by $0.60 [1] - Revenue for the fourth quarter totaled $790.2 million, below expectations of $815.24 million, but represented a 7% increase from $735.9 million in the prior-year quarter [2] - Full-year 2025 revenue reached a record $3.18 billion, up 11% from 2024 [2] Product Revenue Breakdown - Total Tyvaso revenue grew 12% to $464.3 million in the fourth quarter, driven by Tyvaso DPI, which increased 24% to $338.6 million [3] - Growth in Tyvaso revenue was attributed to higher quantities sold due to continued patient expansion and increased commercial utilization linked to Medicare Part D redesign under the Inflation Reduction Act [3] - Orenitram revenue rose 12% to $121.2 million [3] Net Income and Future Outlook - Net income for the quarter reached $364.3 million, or $7.70 per diluted share, compared to $301.3 million, or $6.19 per diluted share, in the fourth quarter of 2024 [4] - For full-year 2025, net income totaled $1.33 billion, up from $1.20 billion in 2024 [4] - Management indicated that the ADVANCE OUTCOMES and TETON-1 clinical programs are expected to deliver pivotal data that could expand treatment options [4]

The upcoming report from RadNet (RDNT) is expected to reveal quarterly earnings of $0.19 per share, indicating a decline of 13.6% compared to the year-ago period. Analysts forecast revenues of $515.37 million, representing an increase of 8% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company announces its earnings, ...

Core Insights - Analysts project Urban Outfitters (URBN) will report quarterly earnings of $1.24 per share, a 19.2% increase year over year, with revenues expected to reach $1.79 billion, reflecting a 9.2% increase from the same quarter last year [1] Earnings Estimates - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating a reassessment by covering analysts [1][2] Key Metrics Projections - Analysts estimate 'Net sales by brand - Free People' will reach $445.42 million, an 8.5% increase from the previous year [4] - 'Net sales by brand - Anthropologie' is expected to be $781.65 million, up 5.2% year over year [4] - 'Net sales by brand - Urban Outfitters' is projected at $391.06 million, reflecting an 8.6% increase from the same quarter last year [4] Retail Operations Insights - The combined estimate for 'Net sales - Retail operations' is $1.56 billion, indicating a 7% increase from the prior year [5] - The estimated 'Number of stores - Retail Operations - Free People' is 269, up from 230 year over year [5] - 'Number of stores - Retail Operations - Anthropologie' is projected to reach 252, compared to 239 last year [6] - 'Number of stores - Retail Operations - Urban Outfitters' is expected to be 254, slightly down from 255 in the same quarter last year [6] - Total 'Number of stores - URBN' is estimated at 785, up from 742 year over year [7] Comparable Store Sales - 'Comparable store sales - Retail Operations - YoY change' is expected to be 5.2%, compared to 5.1% reported in the same quarter last year [7] - 'Comparable store sales - Retail Operations - Free People - YoY change' is estimated at 5.0%, down from 8.0% year over year [8] - 'Comparable store sales - Retail Operations - Anthropologie - YoY change' is forecasted at 3.2%, compared to 8.3% in the same quarter last year [8] Stock Performance - Urban Outfitters shares have decreased by 4.4% in the past month, contrasting with a 1% decline in the Zacks S&P 500 composite [10]

Kratos topped fourth-quarter estimates and projected nearly 20% sales growth for 2026, but weaker first-quarter guidance and high expectations weighed on shares. ...

In its upcoming report, Lowe's (LOW) is predicted by Wall Street analysts to post quarterly earnings of $1.95 per share, reflecting an increase of 1% compared to the same period last year. Revenues are forecasted to be $20.36 billion, representing a year-over-year increase of 9.8%.Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forec ...

Core Viewpoint - Wall Street analysts anticipate a quarterly earnings per share (EPS) of $1.50 for Oneok Inc. (OKE), reflecting a year-over-year decline of 4.5%, while revenues are projected to be $9.49 billion, representing a 35.6% increase from the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised downward by 2.6% over the past 30 days, indicating a reassessment by analysts [1][2] - Changes in earnings estimates are crucial for predicting investor reactions and have shown a strong correlation with short-term stock performance [2] Revenue Projections - Analysts estimate 'Revenues- Natural Gas Gathering and Processing' at $1.46 billion, indicating a year-over-year decline of 20.1% [4] - 'Revenues- Natural Gas Pipelines' are expected to reach $355.94 million, reflecting a 17.5% increase from the prior year [4] - 'Revenues- Refined Products & Crude' are projected at $2.29 billion, suggesting a year-over-year increase of 39.4% [4] Natural Gas Liquids Metrics - The average prediction for 'Revenues- Natural Gas Liquids' is $2.47 billion, indicating a significant decline of 45.3% from the previous year [5] - 'Raw feed throughput - Natural Gas Liquids' is expected to be 1,650.68 thousand barrels per day, compared to 1,306.00 thousand barrels per day reported in the same quarter last year [5] Adjusted EBITDA Estimates - 'Adjusted EBITDA- Natural Gas Liquids' is projected to be $781.79 million, up from $696.00 million in the same quarter last year [6] - 'Adjusted EBITDA- Refined Products & Crude' is expected to be $608.12 million, slightly up from $603.00 million reported in the previous year [6] - 'Adjusted EBITDA- Natural Gas Pipelines' is estimated at $224.21 million, down from $417.00 million a year ago [7] - 'Adjusted EBITDA- Natural Gas Gathering and Processing' is projected to reach $574.43 million, compared to $489.00 million in the same quarter last year [7] Stock Performance - Over the past month, Oneok shares have returned +10.6%, contrasting with a -0.8% change in the Zacks S&P 500 composite [7] - Currently, Oneok holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the overall market in the near future [7]

Wall Street analysts forecast that Jazz Pharmaceuticals (JAZZ) will report quarterly earnings of $6.62 per share in its upcoming release, pointing to a year-over-year increase of 0.3%. It is anticipated that revenues will amount to $1.18 billion, exhibiting an increase of 8.4% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 13% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have re ...

Wall Street analysts forecast that Globus Medical (GMED) will report quarterly earnings of $1.06 per share in its upcoming release, pointing to a year-over-year increase of 26.2%. It is anticipated that revenues will amount to $787.85 million, exhibiting an increase of 19.9% compared to the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during thi ...